Company information
- Ticker
- KNOS
- Country
- United States
- Sector
- Industrials
- Industry
- Waste Management
KRONOS ADVANCED TECHNOLOGIES Business Summary
Kronos Advanced Technologies Inc. (KNOS) is a diversified technology firm generating revenue through the manufacturing, licensing, and direct-to-consumer sale of patented, filter-less air purification systems. The company’s business model is structured across three primary segments: Indoor Air Quality (IAQ) solutions utilizing proprietary high-voltage electrostatic technology, digital health diagnostics through its KronosMD subsidiary, and consumer sleep-wellness via its subsidiary Zyppah, Inc., which recently reported over $2.2 million in annual revenue. Unlike traditional competitors, Kronos leverages a 'no-consumable' model, eliminating recurring HEPA filter costs for users while maintaining FDA 510(k) Class II medical device clearances for virus and bacteria destruction. In the broader market, Kronos competes directly with **Dyson**, **Honeywell**, **Molekule**, and **Blueair**, positioning itself as a high-efficiency, sustainable alternative that targets the sub-micron particle destruction niche often underserved by standard mechanical filtration. Leadership is currently spearheaded by **Greg Rubin**, who serves as Chairman and Interim CEO, focusing on the company's strategic pivot toward medical-grade technology and operational efficiency. Technical innovation and manufacturing strategy are led by **Joseph Florence**, the Chief Operating Officer and Chief Transformation Officer, a veteran electronics manufacturer and former Ernst & Young Entrepreneur of the Year. The board includes notable figures such as **Mary Taylor**, a certified public accountant and former Lieutenant Governor of Ohio, who provides critical oversight on the audit and compensation committees. Founded in 2002 with initial funding from the U.S. military to develop electrostatic air movers, the company’s pedigree is defined by a transition from defense-contracted R&D to the commercialization of a broad intellectual property portfolio in the global health and environmental technology sectors.